A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
Clinical trial NCT06241599 · RECRUITING
Trial details
- NCT number
- NCT06241599
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2026-02-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.